Corine Den Engelsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Corine Den Engelsen has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Kees J. Gorter
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
3 shared publications - Guy E. H. M. Rutten
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, The Netherlands
2 shared publications Guy E. Rutten
Julius Center for Health Sciences and Primary Care; University Medical Center; Utrecht, The Netherlands
2 shared publicationsKees J. Gorter
Julius Center for Health Sciences and Primary Care; University Medical Center; Utrecht, The Netherlands
2 shared publications- Philippe L Salome
Huisartsenzorg IJsselstein, locatie ’t Steyn, IJsselstein, The Netherlands
2 shared publications Philippe L. Salomé
Huisartsenzorg IJsselstein; locatie 't Steyn; IJsselstein, The Netherlands
2 shared publications
Latest Publications
- 1 May 2014
- Published by Springer Nature in Huisarts en wetenschap
- Vol. 57 (5) , 226-230
Het aiothotraject, 15 jaar na de start
- 1 May 2014
- Published by Springer Nature in Huisarts en wetenschap
- Vol. 57 (5) , 226-230
Het aiothotraject, 15 jaar na de start
Development of metabolic syndrome components in adults with a healthy obese phenotype: A 3-year follow-up
There is a lack of data on the progression from a healthy obese phenotype toward an unhealthy obese phenotype and the development of metabolic syndrome (MetS). Our aim was to assess the development of MetS 3 years after screening in centrally obese individuals with a healthy obese phenotype and to evaluate the usefulness of repeated screening. Eighty-eight individuals (mean age 47 years, 88% female) with central obesity as their only MetS component (ATP III criteria) at baseline screening were re-evaluated for MetS status after 3 years. At follow-up, the cardiometabolic risk profile in centrally obese individuals with a healthy phenotype showed a tendency toward deterioration. Thirty-two percent developed at least one additional MetS component, 7% had developed MetS. Nobody had developed type 2 diabetes. An increased triglyceride level (n = 16) and an increased blood pressure (n = 18) were the components most often present at follow-up. The people developing additional MetS components had a lower education level compared with the group that preserved the healthy centrally obese phenotype (80 vs. 71% lower educated, P = 0.35). They also had slightly worse baseline levels of the risk factors. The number of centrally obese individuals developing an unhealthy phenotype in this relatively short follow-up period emphasizes the need for a regular surveillance of cardiometabolic parameters in centrally obese individuals. However, it is questionable whether a repeated screening for type 2 diabetes every 3 years, as recommended by the American Diabetes Association, in this category of patients is appropriate.
Development of metabolic syndrome components in adults with a healthy obese phenotype: A 3-year follow-up
There is a lack of data on the progression from a healthy obese phenotype toward an unhealthy obese phenotype and the development of metabolic syndrome (MetS). Our aim was to assess the development of MetS 3 years after screening in centrally obese individuals with a healthy obese phenotype and to evaluate the usefulness of repeated screening. Eighty-eight individuals (mean age 47 years, 88% female) with central obesity as their only MetS component (ATP III criteria) at baseline screening were re-evaluated for MetS status after 3 years. At follow-up, the cardiometabolic risk profile in centrally obese individuals with a healthy phenotype showed a tendency toward deterioration. Thirty-two percent developed at least one additional MetS component, 7% had developed MetS. Nobody had developed type 2 diabetes. An increased triglyceride level (n = 16) and an increased blood pressure (n = 18) were the components most often present at follow-up. The people developing additional MetS components had a lower education level compared with the group that preserved the healthy centrally obese phenotype (80 vs. 71% lower educated, P = 0.35). They also had slightly worse baseline levels of the risk factors. The number of centrally obese individuals developing an unhealthy phenotype in this relatively short follow-up period emphasizes the need for a regular surveillance of cardiometabolic parameters in centrally obese individuals. However, it is questionable whether a repeated screening for type 2 diabetes every 3 years, as recommended by the American Diabetes Association, in this category of patients is appropriate.
- Open Access
- 13 September 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 778
Remission of screen-detected metabolic syndrome and its determinants: an observational study
Early detection and treatment of the metabolic syndrome may prevent diabetes and cardiovascular disease. Our aim was to assess remission of the metabolic syndrome and its determinants after a population based screening without predefined intervention in the Netherlands.
- 13 September 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 778
Open AccessRemission of screen-detected metabolic syndrome and its determinants: an observational study
Early detection and treatment of the metabolic syndrome may prevent diabetes and cardiovascular disease. Our aim was to assess remission of the metabolic syndrome and its determinants after a population based screening without predefined intervention in the Netherlands.
- Open Access
- 10 September 2012
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 30 (1) , 40-47
One year follow-up of patients with screen-detected metabolic syndrome in primary care: an observational study
Early detection and appropriate treatment of metabolic syndrome (MetS) can modify cardiometabolic risk factors and prevent cardiovascular disease. Optimal screening outcomes require follow-up management of MetS.
- 10 September 2012
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 30 (1) , 40-47
Open AccessOne year follow-up of patients with screen-detected metabolic syndrome in primary care: an observational study
Early detection and appropriate treatment of metabolic syndrome (MetS) can modify cardiometabolic risk factors and prevent cardiovascular disease. Optimal screening outcomes require follow-up management of MetS.
- 29 April 2012
- Published by Springer Nature in Tijdschrift voor praktijkondersteuning
- Vol. 7 (2) , 58
Dieet bij hypertensie
- 29 April 2012
- Published by Springer Nature in Tijdschrift voor praktijkondersteuning
- Vol. 7 (2) , 58
Dieet bij hypertensie
- Open Access
- 1 January 2012
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 11 (1) , 25
High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis
People with central obesity have an increased risk for developing the metabolic syndrome, type 2 diabetes and cardiovascular disease. However, a substantial part of obese individuals have no other cardiovascular risk factors, besides their obesity. High sensitivity C-reactive protein (hs-CRP), a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease, is associated with the metabolic syndrome and its separate components. We evaluated the use of hs-CRP to discriminate between centrally obese people with and without the metabolic syndrome.
- 1 January 2012
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 11 (1) , 25
Open AccessHigh-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis
People with central obesity have an increased risk for developing the metabolic syndrome, type 2 diabetes and cardiovascular disease. However, a substantial part of obese individuals have no other cardiovascular risk factors, besides their obesity. High sensitivity C-reactive protein (hs-CRP), a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease, is associated with the metabolic syndrome and its separate components. We evaluated the use of hs-CRP to discriminate between centrally obese people with and without the metabolic syndrome.
- Open Access
- 1 January 2012
- Published by Taylor & Francis in Dermato-Endocrinology
- Vol. 4 (1) , 33-38
Advanced glycation end products measured by skin autofluorescence in a population with central obesity
Accumulation of advanced glycation end products (AGEs) is enhanced by chronic hyperglycemia and oxidative stress and this process may contribute to the pathogenesis of vascular disease. Skin autofluorescence (AF), a measure of accumulation of AGEs in skin collagen, is associated with vascular disease in patients with diabetes. Because central obesity enhances oxidative stress people with central obesity might already have increased accumulation of AGEs before diabetes or cardiovascular disease become manifest. To test this hypothesis, we compared the distribution of skin AF and its association with clinical and biochemical parameters in individuals with and without central obesity. Skin AF was measured by a validated AGE Reader in 816 persons with and 431 persons without central obesity, aged 20–70 y. Mean skin AF increased with age and smoking and was higher in centrally obese individuals compared with non-obese individuals (p = 0.001, after adjustment for age and smoking p = 0.13). Mean skin AF in the...
- 1 January 2012
- Published by Taylor & Francis in Dermato-Endocrinology
- Vol. 4 (1) , 33-38
Open AccessAdvanced glycation end products measured by skin autofluorescence in a population with central obesity
Accumulation of advanced glycation end products (AGEs) is enhanced by chronic hyperglycemia and oxidative stress and this process may contribute to the pathogenesis of vascular disease. Skin autofluorescence (AF), a measure of accumulation of AGEs in skin collagen, is associated with vascular disease in patients with diabetes. Because central obesity enhances oxidative stress people with central obesity might already have increased accumulation of AGEs before diabetes or cardiovascular disease become manifest. To test this hypothesis, we compared the distribution of skin AF and its association with clinical and biochemical parameters in individuals with and without central obesity. Skin AF was measured by a validated AGE Reader in 816 persons with and 431 persons without central obesity, aged 20–70 y. Mean skin AF increased with age and smoking and was higher in centrally obese individuals compared with non-obese individuals (p = 0.001, after adjustment for age and smoking p = 0.13). Mean skin AF in the...
- 1 November 2011
- Published by Springer Nature in Nederlands Tijdschrift voor Diabetologie
- Vol. 9 (3) , 113-114
PS6 - 33. Development of cardiovascular risk factors in people with central obesity after three years
- 1 November 2011
- Published by Springer Nature in Nederlands Tijdschrift voor Diabetologie
- Vol. 9 (3) , 113-114
PS6 - 33. Development of cardiovascular risk factors in people with central obesity after three years
- 1 January 2010
- Vol. 154, A1028
[Detection of metabolic syndrome by self-measurement of waist circumference].
Determination of both the feasibility and the result in terms of cardiovascular risk factors of self-measurement of waist circumference by apparently healthy people. We also investigated the prevalence of metabolic syndrome in a population of patients aged 20-69 years in IJsselstein, the Netherlands. Cross-sectional survey. All patients aged 20-69 years in the care of a group of General Practitioners (GPs) in IJsselstein, the Netherlands, who were not known to have diabetes, hypertension or dyslipidaemia (n = 11,862), received a tape measure and instructions by mail with the request to measure their waist circumference. Those with an increased waist circumference (> 88 and > 102 cm for women and men, respectively) were invited to undergo investigations to determine whether they conformed to the NCEP ATP III criteria for metabolic syndrome. The prevalence of metabolic syndrome was determined by a combination of these results with file studies of those with already known risk factors for cardiac and vascular disease. The total response rate was 62%. The intraclass correlation between the waist circumference measured by the respondents and by the investigators was 0.80 (p < 0.05). 473 new cases of metabolic syndrome were detected among 1721 persons with an increased waist circumference on self-measurement, 40 % in people younger than 45 years. The total prevalence among those aged 20-69 years in IJsselstein was 15.5%. Only 39% of the people with the metabolic syndrome were already known to have risk factors. A GP initiated screening system for metabolic syndrome, in which self-measurement of waist circumference was the first step, proved to be feasible and reliable. A substantial group of people aged less than 45 years and at increased cardiovascular risk were also detected using this method of population screening.
- 1 January 2010
- Vol. 154, A1028
[Detection of metabolic syndrome by self-measurement of waist circumference].
Determination of both the feasibility and the result in terms of cardiovascular risk factors of self-measurement of waist circumference by apparently healthy people. We also investigated the prevalence of metabolic syndrome in a population of patients aged 20-69 years in IJsselstein, the Netherlands. Cross-sectional survey. All patients aged 20-69 years in the care of a group of General Practitioners (GPs) in IJsselstein, the Netherlands, who were not known to have diabetes, hypertension or dyslipidaemia (n = 11,862), received a tape measure and instructions by mail with the request to measure their waist circumference. Those with an increased waist circumference (> 88 and > 102 cm for women and men, respectively) were invited to undergo investigations to determine whether they conformed to the NCEP ATP III criteria for metabolic syndrome. The prevalence of metabolic syndrome was determined by a combination of these results with file studies of those with already known risk factors for cardiac and vascular disease. The total response rate was 62%. The intraclass correlation between the waist circumference measured by the respondents and by the investigators was 0.80 (p < 0.05). 473 new cases of metabolic syndrome were detected among 1721 persons with an increased waist circumference on self-measurement, 40 % in people younger than 45 years. The total prevalence among those aged 20-69 years in IJsselstein was 15.5%. Only 39% of the people with the metabolic syndrome were already known to have risk factors. A GP initiated screening system for metabolic syndrome, in which self-measurement of waist circumference was the first step, proved to be feasible and reliable. A substantial group of people aged less than 45 years and at increased cardiovascular risk were also detected using this method of population screening.
- 1 August 2009
- Published by Elsevier in Primary Care Diabetes
- Vol. 3 (3) , 165-171
Improved care of type 2 diabetes patients as a result of the introduction of a practice nurse: 2003–2007
- 1 August 2009
- Published by Elsevier in Primary Care Diabetes
- Vol. 3 (3) , 165-171
Improved care of type 2 diabetes patients as a result of the introduction of a practice nurse: 2003–2007